Shares of Blaize Holdings sank 8% to $0.40 after the edge-AI chipmaker disclosed preliminary third-quarter revenue of just $0.5 million — a catastrophic miss against management's own prediction that Q3 would match Q2's $12 million. The company simultaneously cut its full-year 2026 revenue guidance to $32 million–$36 million , down from the $40 million–$43 million range set barely two months ago . For investors already reeling from a stock that has lost over 90% from its 52-week high of $6.76, the update raises existential questions about cash, credibility, and contracts.

  • A Quarter With Almost No Revenue Signals a Broken Delivery Machine. The preliminary $0.5 million figure for Q3 is "significantly lower than expected, suggesting potential operational or market challenges."

Blaize blamed "updated shipment timing expectations and working-capital management for inventory purchases." In plain terms: the company couldn't buy enough parts, or couldn't ship them fast enough, to book meaningful sales — a damning admission for a firm that just weeks ago cut about 26% of its staff to conserve cash.

  • This Is the Second Massive Guidance Cut in One Year. Full-year guidance was already slashed roughly 68% in August, from $130 million to $40 million–$43 million. Now it drops again to $32 million–$36 million, meaning the 2026 revenue outlook has shrunk by roughly $95 million — or about 74% — from its original target. Serial downgrades of this magnitude destroy management credibility and make forward projections essentially untrustworthy.

  • Nearly All Revenue Rides on One Customer. The revised guidance is "influenced primarily by confirmed, non-cancellable purchase orders from NeoTensr," part of a broader contract valued at up to $50 million announced in April 2026.

The company holds only partial inventory to fulfill Q4 orders and is "coordinating with suppliers to secure the remaining stock by year-end." A single-customer revenue story with supply uncertainty is the opposite of a dependable business.

  • Legal Overhang Adds Another Layer of Risk. Multiple law firms, including Robbins LLP and Pomerantz, have filed or are investigating securities class-action lawsuits tied to the guidance collapses. BZAI's price-to-sales ratio sits near 1.06×, far below its historical median of roughly 16.9× — a valuation that screams the market no longer buys the growth story. With $81 million in trailing-twelve-month net losses and a market cap hovering around $63 million, the margin for further error is essentially zero.